NASDAQ: ICUSeastar Medical Holding Corp Stock
$0.53-0.02 (-3.64%)
Updated Jun 2, 2023
ICU Price
$0.53
Fair Value Price
N/A
Market Cap
$7.15M
52 Week Low
$0.45
52 Week High
$22.00
P/E
-0.17x
P/B
-0.66x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$27.27M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.31
Operating Cash Flow
N/A
Beta
0.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ICU Overview
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ICU scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ICU is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ICU is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ICU's short-term liabilities ($8.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more ICU due diligence checks available for Premium users.
Be the first to know about important ICU news, forecast changes, insider trades & much more!
ICU News
Valuation
ICU price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.17x
Industry
780.7x
Market
52.74x
ICU price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.66x
Industry
3.96x
ICU's financial health
Profit margin
Revenue
$0.0
Net Income
-$5.3M
Profit Margin
0%
Assets to liabilities
Assets
$3.4M
Liabilities
$14.3M
Debt to equity
-1.31
ICU's short-term liabilities ($8.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ICU's long-term liabilities ($6.23M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ICU's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ICU's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.3M
Investing
$0.0
Financing
$3.0M
ICU vs Medical Device Stocks
Seastar Medical Holding Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.